|
Archive 2005
PMPRB Notice & Comment
2005 Actual Vs. Forecast CPI-Adjustment Factors
Québec - Bill 130
Formulary Updates 2005
Posted December 22, 2005
New Brunswick
New Brunswick Bulletin #645 effective Dec 22, 2005
Highlights
Benefit Additions: Novo-Atenolol 25mg Tab; Apo-Azithromycin, Co-Azithromycin, Novo-Azithromycin, Sandoz-Azithromycin 250mg Tab; Co-Azithromycin 600mg Tab; Novo-Bisoprolol 5mg Tab, 10mg Tab; Co-Buspirone 10mg Tab; Taro-Clindamycin 1% Top Liq; Apo-Lithium Carbonate SR 300mg SRT; Ran-Metformin 500mg Tab; Gen-Pravastatin 10mg, 20mg, 40mg Tab; Novo-Sertraline 25mg, 50mg, 100mg Caps;
Additional Products Subject to MAP: Estradot 50, Estradot 75, Estradot 100mg Trans Patch
Posted December 19, 2005
Newfoundland
Interchangeable List effective Dec 19, 2005
Posted December 12, 2005
Ontario
Edition 39 Update A Effective Jan 12/06
Highlights
Additions: BenzaClin Top Gel; Myfortic 180mg; 360mg Ent Tab; Reminyl ER 8mg, 16mg, 24mg ER Cap; Telzir 700mg Tab;
Delisted: Apo-Phenylbutazone 100mg Tab; Mellaril 30mg/ml O/L; Novo-Butazone 100mg Tab; PMS-Thioridazine 30mg/ml O/L;
Posted December 6, 2005
Nova Scotia
Pharmacare Bulletin Vol #05-12, Effective Dec 15, 2005
Highlights
Interchangeable Product Additions: Novo-Bisoprolol 5mg, 10mg Tab; RAN-Carvedilol 6.25mg, 12.5mg, 25mg Tab; Apo-Ciproflox .3% Oph Sol; RAN-Ciprofloxacin 250mg, 500mg, 750mg Tab; RAN-Citalopram 20mg, 40mg Tab; Gen-Pravastatin 10mg, 20mg, 40mg Tab; RAN-Zopiclone 5mg Tab.
New interchangeable categories: Azithromycin 250mg Tabs; Clindamycin 1% Top Sol; Cyclosporine 25mg Caps; Sumatriptan 25mg, 50mg, 100mg Tabs; Topiramate 25mg, 100mg, 200mg Tabs.
Posted December 5, 2005
Alberta
Products Removed from AHWDBL - effective Dec 1, 2006
Highlights
Products removed from AHWDBL: As of midnight January 31, 2006 these products will no longer be accepted for all Alberta government-sponsored drug programs: Airomir 100mg/dose metered dose aerosol; Tantum .15% oral rinse; Urispas 200mg Tab; Zaditen .2mg/ml oral syrup, 1mg Tab.
Posted November 25, 2005
Alberta
Additions - Benefit Status change - effective Dec 1, 2005
Highlights
Benefit Status change: No longer requires Special Authorization: Sprivia 18mcg inh cap
November 23, 2005
Ontario
Summary of Changes, Edition 39 Update #4 - effective Dec 6, 2005
Highlights
Products Added: Apo-Salvent 5mg/ml Inh Sol-10ml pk; Novo-Sertraline 25mg, 50mg, 100mg Cap; PMS-Brimonidine 0.2% Oph Sol; Ran-Carvedilol 3.125mg, 6.25mg, 12.5mg, 25mg Tab, Ran-Lovastatin 20mg, 40mg Tab; Rhoxal-Mirtazapine FC 30mg Tab; Sab-Opticort 5mg & 50mcg & 0.5mg.ml Oph/Ot Sol; Taro-Mometasone .1% Oint
November 11, 2005
New Brunswick
MAP List November 2005
Posted November 8, 2005
British Columbia
BCPharmaCare Newsletter, November 7, 2005
Highlights
Special Authority Additions: Actos and Avandia
Posted November 8, 2005
Alberta
DBL Report October 2005
Highlights
Highlights of New Products Added: Crestor 5mg Tab; Eprex 5,000 IU pre-filled syringe by special authority, Oxycontin 5mg sustained-release Tab; Reminyl ER 8mg, 16mg and 24mg by special authorization:
Hightlights of Interchangeable Products Added: Apo-Alendronate 70mg by Special Authorization; Apo-Lithium Carbonate SR 300mg sustatined-release Tab.
Highlights of Special Authorization Criteria changes: Pegasys RBV and Pegetron ; Sporanox 10mg/ml oral solution; VFEND 200mg/vial inj, 50mg & 200mg Tab.
Addition: Neulasta 6mg/0.6ml syringe by special authority; Neupogen criteria change.
Posted November 4, 2005
NIHB
NIHB Drug Bulletin September 2005
Highlights
Open Benefits: Eligard 7.5mg, 22.5mg, 30mg inj (effective Sept 1, 2005); Arimidex 1mg Tab; Teveten Plus 600mg/12.5mg Tab;
New Limited Use Benefits: Humira 40mg/vial inj; Evra 6.0mg/.60mg Transdermal System
Revised Criteria: Cipro 2mg, 10mg; Remicade 200mg/vial inj:
Not Added: Cirpo XL, Gynazole-1, Relpax
Deferred Decision on Listing: Risperdal Consta; Pico-Salax; Avodart; Amevive; Fabrazyme; Replagal; Zavesca; Forteo.
Change in Benefit Status: Prograf, Neoral and generics, Cellcept; Duragesic.
Delisted: Bextra effective April 8, 2005. PPI's Review and change in criteria.
Posted October 27, 2005
British Columbia
Pharmacare Newsletter Oct 25, 2005
Highlights
Additions: Gen-Pravastatin 10mg, 20mg, 40mg Tab; Gen-Amilazide 50/5mg; Novo-Bisoprolol 5mg, 10mg Tab; Ran-Atenolol 50mg, 100mg Tab; Ran-Ciprofloxacin 250mg, 500mg; 750mg Tab; Ran-Citalopram 20mg, 40mg Tab; Ran-Domperidone 10mg Tab; Ran-Lovastatin 20mg, 40mg Tab; Ran-Metformin 500mg, 850mg Tab; Rhoxal-Mirtazapine FC 30mg Tab; Taro-Mometasone .1% ointment; Taro-Simvastatin 10mg, 20mg, 40mg Tab;
Special Authority Additions: Acetaminophen Extra Strength 500mg Tab; Gen-Combo Sterinebs Sol Inh; Gen-Alendronate 10mg Tab; Ran-Carvedilol 3.125mg, 6.25mg, 12.5mg, 25mg Tab; Ran-Zoplicone 5mg, 7.5mg, Ratio-Gabapentin 600mg, 800mg Tab;
New LCA Categories: Alendronate 40mg, 70mg Tab; Cilazapril 1mg, 2.5mg, 5mg Tab; Cyclosporine 25mg, 50mg, 100mg Cap; Leflunomide 10mg, 20mg Tab; Medroxyprogesterone Acetate 100mg Tab; Oxycodone HCL 20mg Tab; Pamidronate Disodium 3mg/ml, 6mg/ml, 9mg/ml; Phenytoin Sodium Oral Susp 125; Sumatriptan 50mg, 100mg Tab; Topiramate 25mg, 100mg, 200mg Tab
October 28, 2005
Ontario
Update #3, Effective Nov 8, 2005
Highlights
Products Added: Gen-Pravastatin 10mg, 20mg,40mg; Gen-Topiramate 25mg, 100mg, 200mg; PMS-Topiramate 25mg, 100mg, 200mg; Ratio-Topiramate 25mg, 100mg,200mg; Rhoxal-Topiramate 25mg, 100mg, 200mg; Taro-Phenytoin 25mg/ml O/L
October 24, 2005
New Brunswick
Bulletin #638 - October 24, 2005
Highlights
Benefit Additions: pms-Oxycodone-Acetaminophen; Ran-Atenolol 500mg & 100mg; Apo-Brimonidine, Ran-Citalopram 20mg & 40mg; Gen-Diltiazem CD 120mg, 180mg, 240mg, 300mg; Gen-Divalproex 125mg, 250mg, 500mg; Ran-Domperidone 10mg; psm-Fosinopril 10mg; Ran-Lovastatin 20mg, 40mg; pms-Medroxyprogesterone 1mg; Apo-Medroxy 100mg; Micozole Vaginal Cream 2%; Taro-Phenytoin 25 mg; Taro-Simvastatin 10mg, 20mg,40mg; Timolol Maleate .25%, .5%; Novo-Warfarin 1mg, 2mg, 2.5mg, 3mg, 4mg, 5mg; Ran-Zopiclone 5mg, 7.5mg;
Special Authority additions: Co-Alendronate 40mg, 70mg; Apo-Alendronate 70mg; Co-Alendronate 70mg; Novo-Alendronate 70mg; Ran-Carvedilol 3.125mg, 6.25mg, 12.5mg, 25mg; Ran-Ciprofloxacin 250mg, 500mg, 750mg; Apo-Ciprofloxacin Oph Liq .3%; Apo-Sumatriptan 100mg; Co-Sumatriptan 100mg; Gen-Sumatriptan 100mg, Novo-Sumatriptan 100mg, pms-Sumatriptan 100mg, Rhoxal-Sumatriptan 100mg.
Note: For purposes of special authorization, MAPs have been established on all interchangeable products in New Brunswick.
Posted October 21, 2005
Nova Scotia
October 2005 Bulletin
Highlights
Review of Wound Care list resulting in revision of PINs for 185 products.
Delisted Products: Novo-Bupropion SR 150mg tab; Co-Pravastatin 10, 20, 40mg tab.
Change to exception criteria: Renagel Tablet. 2 changes to MAC List (sulfasalazine).
Interchangeables added: Gen-Anagrelide.5mg cap; Apo-Bromonidine .2% oph sol, Gen-Diltazem CD 120mg, 180mg, 240mg, 300mg; Gen-Divalproex 125mg, 250mg,500mg; Apo-Fosinopril 10mg, 20mg; Taro-Mometasone .1% oint; Taro-Simvastatin10mg, 20mg, 40mg; Nova-Warfarin 1mg, 2mg, 2.5mg, 3mg, 4mg, 5mg
Posted Oct 19, 2005
Québec
Capsule Oct 19, 2005
Highlights
Criteria revision for Temodal Caps 5mg, 20mg,100mg,250mg
Posted October 4, 2005
NIHB
Updates to Drug Benefit List - Fall 2005
Highlights
Additions including Quebec effective June 1, 2005: Novo-Cilazapril 1mg, 2.5mg, 5mg Tab;
effective July 1, 2005: Alcohol 70% swabs, Apo-Foxinopril 10mg, 20mg Tab, Apo-Lithium Carbonate SR 300mg ER Tab, BCI-Atenolol 100mg Tab, BCI-Metformin 500mg, 850mg Tab, BCI-Pravastatin 10mg, 20mg, 40mg, BCI-Ranitidine 150mg, 300mg Tab, BCI-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tab, Euro-K 10 20MMOL Long Acting Tab, Gen-Lamotrigine 25mg, 100mg, 150mg Tab, K-DUR 1500mg ER Tab, PHL-Valproic Acid E.C. 500mg Cap, PMS-Fosinopril 10mg, 20mg Tab, Ratio-Gabpentin 100mg, 300m, 400mg Cap, Riva-K20 20MMOL ER Tab;
effective August 1, 2005: BCI-Atenolol 50mg Tab, D-Forte 50,000IU Cap, Euro-ASA 80mg Tab, Euro-Cal D 500mg Tab, Euro-Ferrous Sulfate 300mg Tab, Euro-K 600 8MMOL Long Acting Tab, Euro-Lac 667mg/mL Syrup, Euro-Senna 8.6mg Tab,Pediafer 6mg/mL Syrup;
effective September 1, 2005: Eligard 7.5mg/vial, 22.5mg/vial, 30mg/vial Inj., Teveten Plus 600mg & 12.5mg Tab;
Discontinued Drugs: Co-Pravastatin 10mg, 20mg, 40mg Tab, Pediaphen 80mg, 160mg Tab, PMS-Thioridzaine 30mg/mL Sl, Sodium Sulamyd 10% Oph Sol;
Change In Status - Full to Limited Use effective October 1, 2005: Duragesic 25mcg/h, 50mcg/hj, 75mcg/h, 100mcg/h Patch, Apo-Cyclosporine 100mg/mL Sol, Neoral 100mg/mL Sol, Neoral 20mg, 25mg, 50mg, 100mg Cap, Rhoxal-Cyclosporine 100mg Cap, Cellcept 250mg Cap, 500mg Tab, Prograf 0.5mg, 1mg, 5mg Cap, 5mg/mL Inj;
Name Change: Ferovit to Pediafer, Tri-O-Vit to Pediavit;
New Limited Use effective July 1, 2005: Apo-Alendronate 70mg Tab, Novo-Alendronate 70mg Tab,
effective August 1, 2005: Co-Alendronate 40mg, 70mg Tab,
effective October 1, 2005: Evra 6.0mg/0.60-mg Trans Patch, Humira 40mg/vial Inj
Posted October 4, 2005
Saskatchewan
Bulletin effective October 1, 2005
Highlights
New Full Formulary Interchangeable Products: pms-Fosinopril 10mg, 20mg Tab, CO Atenolol 50mg, 100mg Tab, CO Fluvoxamine 50mg, 100mg Tab, Gen-Fosinopril 10mg, 20mg Tab, CO Terbinafine 250mg Tab, CO Gabapentin 100mg, 300mg, 400mg Tab, Novo-Warfarin 1mg, 2mg, 2.5mg, 3mg, 4mg, 5mg Tab, Gen-Divalproex 125mg, 250mg, 500mg EC Tab, BCI Metformin 500mg, 850mg Tab, BCI Pravastatin 10mg, 20mg, 40mg Tab, BCI Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tab, BCI Ranitidine 150mg, 300mg Tab;
New Exception Drug Interchangeables: Novo-Bupropion SR 150mg Tab, pms-Ciprofloxacin 0.3% Oph Sol, Enoxaparin Inj Syr, Gen-Clozapine 25mg, 100mg Tab;
New Exception Drug Status Agents: Humira 40mg/0.8mL Sol for Inj, Zomig Nasal Spray 5mg, Avandament 1mg/500mg, 2mg/500mg, 4mg/500mg, 1mg/1000mg, 4mg/1000mg Tab;
Exception Drug Status Revised Criteria: Cipro XL ER Tab 500mg, 1000mg; Enbrel 25mg Vial, Kineret 100mg/0.67mL pre-fill Syr, Botox 100*IU Pwd, Apo-Desmopressin Int Sol 10ug/dose;
Under Review: Concerta, Apo-Cyclosporine, Rhoxal-Cy closporine, Apo- lozapine, Risperdal Consta, Fabrazyme, Replagal;
Products Not Recommended: Sensipar, Relpax, Gynazole.1, Ciprodex, Aldara, Pennsaid
Posted October 3, 2005
Alberta
Alberta Health & Wellness and Human Resources Formulary Versions effective October 1, 2005
Posted September 27, 2005
Newfoundland
Drug Benefit List dated September 27, 2005
September 26, 2005
Ontario
Update 2 effective October 6, 2005
Highlights
Products Added: Apo-Medroxy 100mg Tab, Gen-Alendronate 10mg Tab, Methotrexate 50mg/2mL Inj Sol 2 mL Pk, Taro-Simvastatin 10mg, 20mg, 40mg Tab
September 23, 2005
New Brunswick
Bulletin effective September 23, 2005
Highlights
Benefit Additions: Combigan 0.2/0.5% Oph Liq, Coversyl 8mg Tab;
Special Authorization Additions: Pegasys RBV 180mcg/mL Inj + 200mg Tab;
Drugs Not Listed: Alphagan P 0.15% Oph Sol, Fuzeon 108mg/vial Inj, Viread 300mg Tab
September 22, 2005
New Brunswick
MAP List - September 2005
September 19, 2005
Nova Scotia
Bulletin (05-09) - September 2005
Highlights
New Exception Drug in LTC facilities: Tamiful.
Changes in MAC: Amiloride 5mg Tab, Betamethasone 17 Valerate 0.1% Cr, Chloroquine Phosphate 250mg Tab, Dipivefrin 0.1% Oph Sol, Trimethoprim 200mg Tab;
New Diabetic Products: Accu-Chek AVIVA 100 and 50, Accu-Chek Multiclix Lancets 204 and 102
September 19, 2005
Manitoba
Amendments to Bulletin #48, effective September 15, 2005
Highlights
Emoxaparin removed from the Drug Interchangeability Formulary.
September 16, 2005
Ontario
Comparative Drug Index 39 Update 01, effective September 16, 2005
Highlights
Products Added: Apo-Ipravent 0.03% Nasal Spray, Novo-Warfarin 1mg, 2mg, 2.5mg, 3mg, 4mg, 5mg Tab, Sodium Aurothiomalate 10mg/mL, 25mg/mL, 50mg/mL Inj Sol-1mL Pk
Posted September 2, 2005
Newfoundland
Benefit List Update effective August 25, 2005
Posted Fall 2005
Ontario
Bulletin 2, Fall 2005
Highlights
Drugs Programs Branch Bulletin: Ontario Drug Benefit Coverage of Testosterone Products;
DQTC and Health Care Professionals: Shared Values and Processes; Testosterone Product Review Results;
Overview of the Evidence for Testosterone Replacement; Pros and Cons of Treatment of Ageing Male Patients
with Nonspecific Symptoms; DQTC Recommendations about Testosterone Products.
Posted September 2, 2005
Ontario
Index 39 Update effective September 27, 2005
Posted Fall 2005
Ontario
Bulletin 1, Fall 2005
Highlights
Drugs Programs Branch Bulletin: Ontario Drug Benefit Coverage of Hormone Replacement Therapy Products;
Formulary Coverage Recommendations by the DQTC; DQTC and Formulary Modernization; Overview of the Evidence for Menopausal Symptoms and Disease Prevention;
Cost Comparison of HRT Products.
Posted September 2, 2005
Alberta
Additions Health & Wellness effective September 1, 2005
Highlights
New Product Added: Novo-Alendronate 70mg Tab
Posted August 24, 2005
Alberta
Additions Health & Wellness effective August 15, 2005
Highlights
New Product Added: Resource Thickenup Oral Powder
Posted August 24, 2005
Alberta
Additions Health & Wellness effective August 1, 2005
Highlights
New Special Authorization: Apo-Alendronate 70mg Tab
Posted August 22, 2005
Manitoba
Bulletin #48 Addendum effective September 15, 2005
Highlights
Part 3 Addition: Aranesp 500mcg/mL Pre-Filled Syringe
Posted August 17, 2005
Manitoba
Bulletin #48 effective September 15, 2005
Highlights
Part 1 Additions: Apo-Brimonidine 0.2% Opht Sol, Apo-Dexamethasone .5mg Tab, Apo-Fosinopril 10mg, 20mg Tab, Apo-Lithium Carbonate SR 300mg Tab, Betaderm 0.05% Crm and Oint, 0.1% Oint, Clasteon 400mg Cap, Co Gabapentin 100mg, 300mg, 400mg Cap, Co Paroxetine 10mg, 20mg, 30mg Tab, Co Terbinafine 250mg Tab, Gen-Combo Sterinebs 0.2/1`.0mg/mL Inh Sol, Gen-Divalproex 125mg, 250mg, 500mg EC Tab, Gen-Lamotrigine25mg, 100mg, 150mg Tab, Methotrexate 10mg Tab, Novo-Bisoprolol 5mg, 10mg Tab, Novo-Cilazapril 1mg, 2.5mg, 5mg Tab, Novo-Metoprol 25mg Tab, Novo-Warfarin 1mg, 2mg, 2.5mg, 3mg, 4mg, 5mg Tab, pms-Fosinopril 10mg, 20mg Tab, ratio-Gabapentin 100mg, 300mg, 400mg Tab, Rhoxal-mirtazapine FC 30mg Tab, Taro-Mometasone 0.1% Oint, Taro-Phenytoin 25mg/mL Susp, Taro-Sone 0.1% Oint, Teveten Plus 600mg/12.5mg Tab, Triaderm 0.1% Top Crm, Tri-Cyclen Lo (21 and 28 Day) Tab;
Part 1 Deletions: Co Pravastatin 10mg, 20mg, 40mg Tab, Endodan 5mg/325g Tab;
Part 2 Added and Amendments: Avodart, pms-Ciprofloxacin, Rhoxal-estradiol derm, Zomig;
Part 3 Additions: Apo-Alendronate 70mg Tab, Co Alendronate 40mg, 70mg Tab, Enoxaparin 30mg, 40mg, 60mg, 80mg Pre-Filled Syringe, Eprex 5000 IU/0.5mL Pre-Filled Syringe, Fluconazole Omega 2mg/mL Inj, Gen-anagrelide 0.5mg Cap, Gleevac, 400mg Tab, Novo-Alendronate 70mg Tab, Novo-Bupropion SR 150mg SR Tab, Rhoxal-cyclosporine 25mg, 50mg Cap, Rhoxal-pamidronate 3mg, 6mg, 9mg Inj, Supeudol 20 20mg Tab,
Special Consideration Process: Humira; Multiple New Interchangeable Categories and Products, Product Formulary Deletions, Product Price Changes
Posted August 17, 2005
New Brunswick
MAP List - August 2005
Posted August 16, 2005
Prince Edward Island
Newsletter effective July 1, 2005
Highlights
Added Drugs: Aricept, Exelon, Reminyl
Posted August 16, 2005
British Columbia
Newsletter effective August 15, 2005
Highlights
New Limited Coverage (SA): Avodart 0.5mg Cap, Humira 40mg/0.8mL Inj, Keppra 250mg, 500mg, 750mg Tab, Teveten Plus 600mg/12.5mg Tab, VFEND 50mg, 200mg Tab;
New Benefits: Axert 6.25mg, 12.5mg Tab, Combigan 0.2%/0.5%/mL Opth Sol, Serc 24mg Tab, Urso DS 500mg Tab, Xalacom 50mcg/ml / 5mg/mL Opht Sol, Accu-Check Aviva Test Strip;
Non-Benefits: Pegasys, Periostat, Relpax, Remodulin, Sensipar, Xatral, Zavesca, Zyprexa
Posted August 11, 2005
Ontario
Update G3 effective August 19, 2005
Highlights
Added Products: Co-Alendronate 70mg Tab, Novo-Alendronate 70mg Tab, Novo-Bisoprolol 5mg 10mg, Tab
Posted August 9, 2005
Alberta
Additions effective August 15, 2005 - AHREDBS
Highlights
New Drug Added: Resource Thickenup Oral Powder
Posted August 2, 2005
Nova Scotia
Bulletin (05-08) - July 2005 effective August 1, 2005
Highlights
Additions to Exception Criteria: Remicade, Aldara, Plavix;
New Full Benefits: Apo-Quinine 200mg, 300mg Cap, Combigan Oph Sol, Tiazac XC 120mg, 180mg, 240mg, 300mg, 360mg Tab;
New Exception Status: Gleevec 100mg, 400mg Tab,
Community Services Only: Yasmin 21 and 28 Tab;
Not Insured: Telzir, Vigamox, Zymar;
Change to MAC List: Brimonidine 0.2% Oph Sol, Ibuprofen 300mg, 400mg Tab, Mometasone 0.1% Oint;
Discontinued Products: Aldomet, Ampicillin, Ancotil, Ceftin, Cogentin, Colchicine, Coptin, Cuprimine, Erythromycin, Flexeril, Ilosone, Indocid, Intal, Largactil, Motrin, Myochrysine, Nu-Desipramine, Ortho-Novum, Piportil, Prednisone, Rhodacine, Rhodis, Rhotrimine, Rhovail, Rhoxal-Loperamide, Streptomycin, Suprax, Surmontil
Posted July 26, 2005
Nova Scotia
Bulletin - July 2005 effective August 1, 2005
Highlights
MAC List; New Interchangeable Product: pms-Fosinopril
Posted July 14, 2005
Newfoundland/Labrador
Drug Benefit List - July , 2005
Posted July 12, 2005
New Brunswick
MAP List - July 2005
Posted July 5, 2005
NIHB
Updates Summer 2005
Highlights
Quebec Benefit List Additions effective April 1, 2005: Apo-Dexamethasone, Climara, Co-Gabapentin, Mavik, Methotrexate, Novofine Needle, PMS-Ciprofloxacin, Riva-Flconazole, Sab-Anuzinc HC Plus, Serc, Synthroid, Tiazac, Viracept;
effective May 1, 2005: ASA, Co-Paroxetine, Novo-Metoprol CT;
Other Provinces Benefit List Additions effective April 1, 2005: Apo-Dexamethasone, Climara, Co-Gabapentin, Mavik, Methotrexate, Novofine Needle, PMS-Ciprofloxacin, Riva-Fluconazole, Sav-Anuzinc HC Plus, Serc, Synthroid, Tiazac, Viracept,
effective May 1, 2005: ASA, Co-Paroxetine, Novo-Metoprol CT;
Discontinued: Bextra, Iletin II Lente, Isoptin, Lin-Pravastatin, Neutrogena, Penta-Doxycyline, Pentasa, PMS-Cefaclor, PMS-Isoniazid, PMS_Lactulose, PMS-Pot Gluconate
Posted July 5, 2005
Alberta
Additions - July 1, 2005
Highlights
New Benefit: Yasmin 21 and 28 3mg 0.03 mg Tab; New Special Authorization: VFEND, 40mg, 200mg Tab, 200mg/Vial Inj
Posted July 5, 2005
Saskatchewan
Bulletin 103 - July 2005
Highlights
New Interchangeables: pms-Fosinopril 10mg, 20mg Tab, CO Atenolol 50mg, 100mg Tab, CO Fluvoxamine 50mg, 100mg Tab, Gen-Fosinopril 10mg, 20mg Tab, CO Terbinafine 250mg Tab, CO Gabapentin 100mg, 300mg, 400mg Tab, Novo Warfarin 1mg, 2mg, 2.5mg, 3mg, 4mg 5mg Tab, Gen-Divalproex 125mg, 250mg, 500mg EC Tab, BCI Metformin 500mg, 850mg Tab, BCI Pravastatin 10mg, 20mg Tab, BCI Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tab, BCI Ranitidine 150mg, 300mg Tab;
New Exception Drug Status Interchangeable: Novo-BupropionSR 150mg Tab, pms-Ciprofloxacin Opht Sol 0.3%, Enoxaparin Inj; Gen-Clozapine 25mg, 100mg Tab;
New Exception Drugs: Humira, Inj 40mg/0.8mL, Zomig Nasal Spray 5mg, Advandamet Tab;
Exception Drug Status Revised Criteria: Cipro XL 500mg, 1000mg ER Tab, Enbrel, Kineret, Botox, Apo-Desmopressin, DDAVP;
Under Review: Concerta, Apo-Cyclosporine, Rhoxal-Cyclosporine, Apo-Clozapine, Risperdal Consta, Fabrazyme, Replagal;
Not Recommended: Sensipar, Relpax, Gynazole, Ciprodex, Aldara, Pennsaid:
Delisted effective October 1, 2005: Cytomel; Visudyne - reimbursed by the health regions.
Posted June 29, 2005
Newfoundland/Labrador
Drug Benefit List - June 29, 2005
Posted June 29, 2005
Ontario
Update G2 effective July 14, 2005
Highlights
New Benefits: Apo-Fosinopril 10mg, 20mg Tabs, PMS-Fosinopril 10mg, 20mg Tabs;
New Limited Use Benefits: Apo-Alendronate 70mg Tab, Gen-Lamotrigine 25mg, 100mg, 150mg Tabs, Ratio-Gabapentin 100mg, 300mg, 400mg Caps
Posted June 24, 2005
Alberta
DBL Report July 2005
Highlights
Products Added: Salofalk 1000mg Supp, Tri-Cyclen Lo OC, Zomig 5mg Nas Spry;
Special Authorization Criterial Changes: Aranesp, Imitrex DF, Pegasys RBV;
Interchangeable Products Added: Novo-Bupropion SR, 150mg Tab effective July 1, 2005, Novo-Cilazapril 1mg, 2.5mg, 5mg Tab effective May 1, 2005
Posted June 24, 2005
Nova Scotia
Bulletin - June 2005 effective July 1, 2005
Highlights
No Longer Interchangeable: Rhoxal-Ticlopidine 250mg Tab;
Discontinued Products: Rhoxal-Lperamide 2mg Cap, Rhoxal-Sotalol 80mg Tab;
New Interchangeable Products - see list
Posted June 24, 2005
Ontario
BBS June 22, 2005
Highlights
Delisted - Co-Pravastatin 10mg, 20mg, 40mg Tabs
Posted June 20, 2005
New Brunswick
Bulletin effective June 17, 2005
Highlights
Benefit Additions: ratio-Oxycocet 325/5mg Tab, Novo-Bupropion SR 250mg Tab, Novo-Cilazapril 1mg, 2.5mg, 5mg Tab, ratio-Gabapentin 100mg, 300mg, 400mg Cap, Gen-Lamotrigine 25mg, 100mg, 150mg Tab, Rhoxal-Loperamide 2mg Tab, Co-Paroxetine 10mg, 20mg, 30mg Tab;
Additional Products Subject to MAP: Rhoxal-Sotalol 80mg Tab, Triamcinolone Acetonide 40mg/mL Sus
Posted June 16, 2005
New Brunswick
Interchangeable/Formulary List June 2005
Posted June 13, 2005
New Brunswick
MAP List effective June 2005
Posted June 8, 2005
Ontario
Update G1 effective June 13, 2005
Highlights
Additions: Novo-Cilazapril 1mg, 2.5mg, 5mg Tabs, Taro-Teronazole 0.4% Cr
Posted June 2, 2005
Nova Scotia
May Bulletin effective June 1, 2005
Highlights
Exception Criteria Change for Respiratory Fluoroquinolones; Interchangeability Approved for Clozapine with Clozaril: Gen-Clozapine;
New Products: Cesamet 0.5mg Cap,
New Exception Status Products: Climara 25 and 75, Nutropin AQ Pen Cartridge, Vitamin B12 500mcg Tab, Vfedn 50mg, 200mg Tab;
Not Insured: Levaquin 750mg Tab, Relpax 20mg, 40mg Tab, Sensipar 30mg, 60mg, 90mg Tab;
New Interchangeable Products: Rhoxal-Acebutolol, Rhoxal-Zopiclone
Posted June 1, 2005
Québec
Capsule June 2005
Highlights
Additions: Relpax,Telzir,Yasmin;
Exception Status Additions: Concerta,Lantus,Norprolac,Risperdal Consta, Vfend, Xalacom;
Exception Status Criteria Change: Botox, Neocate, Neocate Junior;
Denied due to Therapeutic Value: Amevive, Humira, Nuvaring, Vigamox;
Denied due to Price: Cutivate
Posted May 31, 2005
New Brunswick
Bulletin effective May 31, 2005
Highlights
Benefit Additions: Reyataz 150mg, 200mg Cap, 3TC 300mg Tab, Remeron RD 15mg, 30mg, 45mg Tab;
Special Authorization Additions: Axert 6.25mg, 12.5mg Tab, Methadone HCI 1mg, 5mg, 10mg, 25mg Tab; Methadone Compounded Oral Solution, Detrol LA 2mg, 4mg Cap,
Revised Special Authorization: Ditropan XL 5mg, 10mg Tab, Detrol 1mg, 2mg Tab, Foradil 12 mcg Inh Cap, Oxeze 6mcg, 12mcg Inh Turb, Serevent 25mcg MDH, 50mcg Diskus, Symbicort 6mcg/100mcg, 6mcg/200mcg MDI, Advair, 25/125mcg,25/250mcg MDI, 50/100mcg,50/250mcg,50/500mcg Diskus Dry Pwd Inh, Gleevec 10mg Capsule;
Drugs Not Listed: Iressa, Metadol, Pregvit, Evra
Posted May 19, 2005
British Columbia
BCPharmaCare Newsletter, May 18, 2005
Highlights
New LCA or RDP Drugs and new LCA Categories effecitve June 20, 2005 - see list for details; Bextra - existing special authorities terminated effective April 7, 2005; Effective June 20, 2005:
New Benefits: Cipro XL 500mg, 1000mg MR Tabs, Edecrin 25mg Tab, Lescol XL 80mg ER Tab, Risperdal M-Tab 0.5mg, 1mg, 2mg Tabs;
New Special Authority Drugs: Humatrope 24mg Cart, Nuropin AQ Pen 20mg/2mL Pen Cart, Pegasys RBC 100mg/Tab vial and Syringe; Pegetron Redipen 50mcg0.5mL/200mg, 80mcg/0.5mL/200mg, 100mcg/0.5mL/200mg, 120mcg/0.5mL/200mg, 150mcg/0.5mL/200mg Caps, Zyprexa-Zydis 15mg Tab;
Changes to LCA Prices: Oxycodone Tab 5/325mg, Dexamethasone Tab 0.5mg, Mirtazapoine Tab 30mg
Posted May 13, 2005
New Brunswick
MAP Revision effective May 13, 2005
Posted May 12, 2005
Ontario
ODB Update G effective May 24, 2005
Highlights
New Single Source Drugs: Eligard 30mg Inj Pref Syr-Kit, Teveten Plus 600mg & 12.5mg Tab, Tiazac XC 120mg, 180mg, 240mg, 300mg, 360mg ER Tab, Viracept 625mg Tab (Note: for the treatment of HIV/AIDS the prescriber must be approved);
New Multi-Source Drugs effective January 25, 2005: Co-Etidronate, Gen-Fosinopril 10mg, 20mg Tabs, Novo-Lefunomide 10mg, 20mg Tabs; Novo-Levofloxacin 250mg, 500mg Tabs, PMS-Methimazole 5mg Tab, Rhoxal-Acebutolol 100mg, 200mg, 400mg Tabs, Rhoxal-Sotalol 160mg Tab, effective February 25, 2005: Novo-Bupropion SR 150mg Tab;
Delisted Drugs: Estinyl 0.05mg, 0.5mg Tab, Muro-128 5% Oph Oint, 5% Oph Sol, Palladone XL 12mg, 16mg, 24mg CR Cap, PMS-Methimzole 5mg Tab, Scheinpharm Ranitidine 150mg, 300mg Tab, Sun-Benz 0.15% Orl Rinse;
New Drug Benefit Prices: Apo-Ciproflox 500mg, 750mg Tab, Apo-Dexamethasone 4mg Tab, Apo-Leflunomide 10mg, 20mg Tab, Ativan 0.5mg Tab;
Manufacturer Discontinued Products: Alupent, Berotec, Coptin, Dulcolax, Intal, Mexitil, Myclo-Derm, Myclo-Gyne, Ortho-Novum 1/50
Posted May 1, 2005
Ontario
ODB Update F3 effective April 28, 2005
Highlights
New Products Added: Apo-Dexamethasone 0.5mg Tab, Co-Paroxetine 20mg, 30mg Tab, Gen-Divalproex 125mg, 250mg 500mg Ent Tab, Rhoxal-Loperamide 2mg Cap
Posted May 3, 2005
Alberta
Additions effective May 1, 2005
Highlights
New Interchangeable Products with LCA: Novo-Cilazapril 1mg, 2.5mg, 5mg Tabs
Posted April 29, 2005
Alberta
Additions effective April 15, 2005
Highlights
New Drug Products Added: Betaderm Mild 0.05%, 0.1% Top Oint, Hyderm 1% Top Crm, Ratio-Nystatin 500,000 Tab;
New Interchangeable Products with LCA: Betaderm Mild, Betaderm Regular, Ratio-Tecnal;
New Interchangeable Products: Endocet, Endodan, Prednisolone Acetate
Posted April 22, 2005
Alberta
DBL Reprot April 2005
Highlights
New Special Authorization: Cancidas 50mg, 70mg Inj,
New Products Added: Cesamet 0.5mg Capsule, Pegetron Redipen Inj Kit 80mcg,100mcg,120mcg,150mcg/0.5mL;
Products Not Added: Concerta, Cutivate, Gentlax-S;
Product Removed: Bacid (claims honored up to June 15, 2005)
Posted April 20, 2005
Newfoundland/Labrador
Interchangeable List - April 20, 2005
Posted April 20, 2005
Alberta
Alberta Health & Wellness Additions effective April 15, 2005
Highlights
Products Added: Betaderm Mild 0.05%, 01% Top Oint, Hyderm 1% Top Crm, Ratio-Nystatin 500,000 Unit Tab;
New Interchangeable Products affected by LCA Pricing: Betaderm Mild, Betaderm Regular, Ratio-Tecnal Capsule;
New Interchangeable Products: Endocet Tab, Endodan Tab, Prednisolone Acetate 1% Opht Susp
Posted April 20, 2005
Alberta
Changes to Alberta Health & Wellness Benefit List effective April 1, 2005
Highlights
New Special Authorization: Cancidas 50mg, 70mg Inj, Pegetron Redipen Inj Kit 80mcg,100mcg,120mcg,150mcg/0.5mL, Zometa Concentrate 4mg/5mL Inj, Co Etidronate 100mg Tab, Octreotide Acetate Omega 50mcg, 100mcg, 200mcg, 500mcg/mL Inj;
Discontinued Special Authorization: Linmegestrol 160mg Tab, Nu-Ampi 25mg, 50mg/mL Orl Susp, Pms-Flutamide 250mg Tab;
Products Added: Apo-Bisoprolol 5mg, 10mg Tab, Apo-Dexamethasone 0.5mg Tab, Apo-Methylphenidate 10mg, 20mg Tab, Cesamet 0.5mg Cap, Co Metformin 500mg, 850mg Tab, Gen-Clindamycin 150mg, 300mg Cap, Novo-Mirtazapine 30mg Tab, Novo-Ranidine 15mg/mL Orl Sol, Ranitidine 25mg/mL Inj, Taro-Terconazole 0.4% Vag Crm;
Discontinued Products: See Bulletin;
Deleted Product: Bacid Capsule
Posted April 13, 2005
Nova Scotia
April 2005 Bulletin
Highlights
New Products Full Listing: NovoFine Pen Needles 32 x6mm(100);
New Exception Status: Humira 40mg/vial Inj, Singulair 4mg/pkt Gran;
Not Insured: Periostat 20mg Cap;
Criterita Updates: Enbrel;
No Longer Interchangeable: pms-Gentamicin;
New Interchangeable Products: Gen-Clindamycin, Apo-Dexamethasone, Co-Etidronate, Novo-Leflunomide, Co Metformin, Apo-Methylphenidate, pms-Ofloxacin;
New Interchangeable Categories: Alfentanil, Anagrelide, Ciprofloxacin, Clonidine HCI, Levofloxacin, Tizanidine
Posted April 11, 2005
New Brunswick
MAP List, April 2205
Posted April 6, 2005
New Brunswick
Benefit Changes, April 6, 2005
Highlights
Interchangeable Product Additions: Rhoxal-Acebutolol 100mg, 200mg, 400mg Tab, Ciloxan, 0.3% Liq Oph, pms-Ciprofloxacin 0.3% Liq Oph, Gen-Clindamycin 150mg, 300mg Cap, Dixarit 0.025mg Tab, Apo-Clonidine 0.025mg Tab, Apo-Dexamethasone 0.5mg Tab, Taro-Fluconazole 50mg, 100mg Tab, Gen-Fosinopril 10mg, 20mg Tab, Sab-Proctomyxin Hc 1%/1%/0.5%/0.5% Oint, Sab-Proctomyxin HC 10mg/10mg/5mg/5mg Sup, Co-Gabapentin 100mg, 300mg, 400mg Cap, Rhoxal-Gliclazide 80mg Tab, Sab-Anuzinc HC 0.5%/0.5% Ont, Sab-Anuzine 10mg/10mg Sup, Novo-Leflunomide 10mg, 20mg Tab, Levaquin 250mg, 500mg Tab, Novo-Levofloxacin 250mg, 500mg Tab, pms-Ofloxacin 0.3% Oph Liq, Losec 20mg Cap, Apo-Omeprazole 20mg Cap, Rhoxal-Paroxetine 20mg, 30mg Tab, Sab-Anuzinc HC Plus 1%/0.5%/0.5% Ont, Sab-Anuzinc HC Plus Sup, Co-Terbinafine 250mg Tab, Zanaflex 4mg Tab, Apo-Tizanidine 4mg Tab, Rhoxal-Zopiclone 5mg, 7.5mg Tab
Posted April 6, 2005
NIHB
Spring Update - April 2005
Highlights
Additions (All Provinces including Quebec) effective December 1, 2004: Taro-Fluconazole 50mg, 100mg Tab,
Effective January 1, 2005: Apo-Clonidine 0.025mg Tab, Apo-Methylphenidate 10mg, 20mg Tab, Calcium 500mg Tab, Co-Edidronate 200mg Tab, co-Metformin 500mg, 850mg Tab, Dom-Simvastatin 5mg, 10mg, 20mg, 40mg 80mg Tab, PMS-Amitriptyline 10mg, 25mg, 50mg Tab, PMS-Oxycodone-Acetaminopen 5mg/325mg Tab, Precision Plus Electrodes Strip, Rhoxal-Acebutolol 100mg, 200mg, 400mg Tab, Rhoxal-Anagrelide 0.5mg Cap, Rhoxal-Gliclazide 80mg Tab, Rhoxal-Loperamide 2mg Tab, Rhoxal-Sotalol 80mg, 160mg Tab, Taro-Terconazole 0.4% Crm, Vitamih E 200IU Cap,
Effective February 1, 2005: 3TC 300mg Tab, Asaphen EC 162mg DR Tab, Gen-Fosinopril 10mg, 20mg Tab, Mavik 4mg Capsule, PHL- Loxapine 5mg, 10mg, 25mg, 50mg, Tab, Riva-Indapamide 1.25mg Tab,
Effective March 1, 2005: Aerochamber Max VHC with Adult Mask, with Child Mask, with Infant Mask, with Mouthpiece;
Special Formulary for Chronic Renal Failure Patients Benefit List: see bulletin.
Posted April 5, 2005
Saskatchewan
Benefit List - April 1, 2005
Highlights
Additions (All Provinces including Quebec) effective December 1, 2004: Taro-Fluconazole 50mg, 100mg Tab,
Effective January 1, 2005: Apo-Clonidine 0.025mg Tab, Apo-Methylphenidate 10mg, 20mg Tab, Calcium 500mg Tab, Co-Edidronate 200mg Tab, co-Metformin 500mg, 850mg Tab, Dom-Simvastatin 5mg, 10mg, 20mg, 40mg 80mg Tab, PMS-Amitriptyline 10mg, 25mg, 50mg Tab, PMS-Oxycodone-Acetaminopen 5mg/325mg Tab, Precision Plus Electrodes Strip, Rhoxal-Acebutolol 100mg, 200mg, 400mg Tab, Rhoxal-Anagrelide 0.5mg Cap, Rhoxal-Gliclazide 80mg Tab, Rhoxal-Loperamide 2mg Tab, Rhoxal-Sotalol 80mg, 160mg Tab, Taro-Terconazole 0.4% Crm, Vitamih E 200IU Cap,
Effective February 1, 2005: 3TC 300mg Tab, Asaphen EC 162mg DR Tab, Gen-Fosinopril 10mg, 20mg Tab, Mavik 4mg Capsule, PHL- Loxapine 5mg, 10mg, 25mg, 50mg, Tab, Riva-Indapamide 1.25mg Tab,
Effective March 1, 2005: Aerochamber Max VHC with Adult Mask, with Child Mask, with Infant Mask, with Mouthpiece;
Special Formulary for Chronic Renal Failure Patients Benefit List: see bulletin.
Posted April 5, 2005
Newfoundland/Labrador
Benefit List - April 1, 2005
Posted March 29, 2005
New Brunswick
Drug Benefit List - March 2005
Posted March 28, 2005
Newfoundland/Labrador
Highlights of March 2005 Formulary Update
Highlights
Additions: Apo-Dipyridamole FC 50mg Tab, Atrovent HFA Inh Aer, Estradot 25mcg/day Patch, Apo-Fluphenaziune 25mg/mL Inj, Premplus 5mg Tab;
New Interchangeable Categories: Amiloride Hydrochloride 5mg Tab, Atenolol/Chlorthalidone 50/25mg & 100/25mg Tab, Clonidine 0.025mg Tab, Ofloxacin Opht Sol 0.3%;
Category Removed: Nitroglycercin Sublingual Spray 0.4mg/metered dose.
Posted March 24, 2005
Ontario
Update F2 effective March 31, 2005
Highlights
New Interchangeable Products: Apo-Lactulose 666.7mg/mL O/L Sol, Apo-Methylphenidate 10mg Tab, Co-Gabapentin 100mg, 300mg, 400mg Cap.
Posted January 4, 2005
Saskatchewan
Bulletin April 2005
Highlights
New Full Formulary Listing: Teveten Plus 600mg/12.5mg Tab, Advodart 0.5mg Cap;
Change from EDS to Full Listing: Alphagan 0.15% Opth Sol; New Exception Drug Status Agents: Levaquin 750mg Tab, Cipro XL 500mg Tab, Zymar 0.3% Opht Sol, Viracept 625mg Tab, Edecrin 25mg Tab;
New EDS Interchangeable Agents: Taro-Fluconazole 50mg, 100mg Tab, Rhoxal-Estradiol Derm 50ug/day, 75ug/day, 100ug/day, Novo-Levofloxacin 250mg, 500mg Tab, Novo-Meloxicam 7.5mg, 15mg Tab, Apo-Leflunomide 10mg, 20mg Tab, Novo-Leflunomide 10mg, 20mg Tab, Apo-Tizanidine 4mg Tab;
New Full Formulary Interchangeable Listings: Rhoxal-Anagrelide 0.5mg Cap, Rhoxal-Loperamide 2mg Tab, Apo-Methylphenidate 10mg, 20mg Tab, Apo-Dexamethasone 0.5mg Tab, CO Metformin 450mg, 850 Tab, CO Etidronate 200mg Tab, pms-Amitriptyline 10mg, 25mg, 50mg Tab, Novo-Metoprol CT 25mg Tab, BCI Salbutamol 1mg/mL, BCI Fluvoxamine 50mg, 100mg Tab, BCI Atenolol 50mg, 100mg Tab, Gen-Clindamycin 150mg, 300mg Cap, Rhoxal-Paroxetine 10mg, 20mg, 30mg, Rhoxal-Sotalol 80mg, 160mg Tab, Rhoxal-Acebutolol 200mg, 400mg Tab, Taro-Terconazole 0.5% vag crm, Novo-Mirtazapine 30mg Tab;
Exception Drug Status with Revised Criteria: Prograf 0.5mg, 1mg, 5mg Cap, Celebrex 100mg, 200mg Cap;
Products Under Review: Concerta, Sensipar, Visudyne, Humira, Zomig, Yasmin 21, Yasmin 28, Ebixa, Norprolac, Amevive, Relpax, Gynazole, Apo-Cyclosporine, Rhoxal-Cyclosporine, Ciprodex, Replagal 1mg/mL Inj, Fabrazyme Inj, Gen-Clozapine 25mg, 100mg Tab;
Under Review CDR: Lantus, Strattera, Telzir, Aldurazyme, VFend;
Not Recommended: Suplasyn 10mg/mL Pre-Fill Syr, Cystistat 40mg/50mL Vial, Zavesca 100mg Cap, Aldara 5% Top Crm, Oxytrol 3.9mg/day Trans Sys, Forteo 250ug/mL pre-fill Pen, Remodulin 1.0mg/mL, 2.5mg/mL, 5.0mg/mL, 10mg/mL, Rhoxal-Zopiclone 5mg, 7.5mg Tab;
Health Region Benefit at 100% meeting specific criteria: Visudyne
Posted March 17, 2005
Newfoundland/Labrador
Updated Benefit List effective March 16, 2005
See List.
Posted March 15, 2005
New Brunswick
Bulletin 617 effective March 15, 2005
Highlights
Regular Benefit Additions: Buro-Sol 0.5%/0.03% Otic Liq, 0.35%/0.023% Top Pwr. Cardizem CD, Ratio-Diltiazem CD, Apo-Diltiaz CD, Nu-Diltiaz CD, Novo-Diltiazem CD Rhoxal-Diltiazem CD 120mg, 180mg, 240mg, 300mg, Rosasol 1% Top Crm, Nasonex 50mcg Nas Aem, Monopril, Novo-Fosinopril 10mg, 20mg Tabs, Coversyl 2mg, 4mg Tab, Coversyl Plus 4mg/1.25mg Tab, Accupril 5mg, 10mg, 20mg, 40mg Tab, Accuretic 10mg/12.5mg, 20mg/12.5mg, 20mg/25mg Tab, Mavik 1mg, 2mg, 4mg Cap, Ziagen 30mg Tab, 20mg/mL Liq, Trizivir 300mg/150mg/300mg Tab, Agenerase 50mg, 150mg Cap, 150mg/mL Liq, Videx EC 125mg, 200mg, 250mg, 400mg Cap, Videx Oral Solution 10mg/mL Pws, Sustiva 50mg, 100mg, 200mg Cap, 600mg Tab, Kaletra 133.3mg/33.3mg Cap, Kaletra Oral Solution 80mg/mL/20mg/mL Liq, Viracept 250mg Tab, 50mg/gm Pwr, Viramune 200mg Tb, Fortovase 200mg Cap, Invirase 200mg Cap;
Special Authorization Additions: Cipro HC Otic solution 2mg/mL/10mg/mL Susp;
Not Listed: Rescriptor 100mg Tab
Posted March 11, 2005
Manitoba
Bulletin 47, effective May 7, 2005
Highlights
Part 1 Additions: Cesamet 0.5mg Cap, Gen-Fosinopril 10mg, 20mg Tabs, Mavik 0.5mg, 5mg Caps, Remeron RD 15mg, 30mg, 45mg OD Tab, Synthroid 137mcg Tab, Tiazac XC 120mg, 180mg, 240mg, 300mg, 360mg ER Tab, Viracept 625mg Tab;
Part 2 Additions: Novo-Levofloxacin 250mg, 500mg Tab, Nutrophin AQ 5mg/mL Pen Cart, Singulair 4mg Orl Gran, Taro-Fluconazole 50mg, 100mg Tab;
Criteria Addition: Pariet 10mg, 20mg Tab;
Part 2 Deletions (moved to Part 3): Actonel 5mg, 30mg, 35mg Tab, Apo-Alendronate 10mg Tab, Co Etidronate 200mg Tab, Didronel 200mg Tab, Fosamax 10mg, 40mg, 70mg Tab, Gen-Etidronage 200mg Tab, Novo-Alendronate 10mg Tb, Wellbutrin SR 100mg, 150mg ER Tab;
Part 3 Deletions: Actonel 5mg, 30mg, 35mg Tab, Apo-Alendronate 10mg Tab, Apo-Tizanidine 4mg Tab, Co-Etidronate 200mg Tab, Didronel 200mg Tab, Fosamax 10mg,40mg, 70mg Tab, Gen-Etidronate 200mg Tab, Novo-Alndronate 10mg Tab, Novo-Leflunomide 10mg, 20mg Tab, Pegasys RBV 180mcg/mL + 200mg; 180mcg/0.5mL + 200mg Inj + Tab, Wellbutrin SR 100mg, 150mg ER Tab (See bulletin for details on excluded critieria);
New Interchangeable Categories: Levofloxacin 250mg, 500mg Tab, Tizanidine HCI 4mg Tab;
New Interchangeable Products: Fluconazole 50mg, 100mg Tab, Fosinopril Sodium 10mg,. 20mg Tab, Leflunomide 10mg, 20mg Tab;
Product Deletions: Allernmix, Allernix Extra Strength, Alti-Acyclovir, Alti-Bromazepam, Alti-Cyclobenzaprine, Alti-Diltiazem, Alti-Doxepin, Alti-Prazosin, Asmavent, Atrovent (CFC), Betaderm, Chlorpromanyl, Cortoderm, Deproic, Diclotec, Diovan, Docusate Sodium, Effexor, Fluoderm, Gemfibroil, Macrodantin, Motilidone, Nadostine, Neotopic, Novo-Chlorpromazine, Novo-Clopamine, Novo-Desipramine, Novo-Diltiazem SR, Novo-Dipiradol, Novo-Maprotiline, Novo-Meprazine, Novo-Salmol, Novo-Tenoxicam, Novo-Tripramine, Novov-Veramil, Nyaderm, Orafen, Peptol, Pilocarpine Hydrochloride, ratio-Desipramine, Renagel, Rubion, Salofalk, Serc, Sotamol, Stieva-A, Surmontil, Synflex, Synflex-DS, Taro-Sone, Thiotepa, Thio Tepa, Triaderm, Ultradol, Viaderm KC, Rhoxal-paroxetine;
Category Deletion and Intervchangeable Product Price Changes (see bulletin for details);
Discontinued Products: Atromid-S, Coptin, Glysennid, Hydromorphone, Intal, Myochrysine, Ortho-Novum 1/50, Palladone XL, Piportil L4, Serc, Surmontil
Posted March 10, 2005
Nova Scotia
March 2005 Bulletin
Highlights
Change to Maximum Allowable Cost List: Octreotide;
New Full Benefits: Teveten Plus 600mg/12.5mg Tab, Allkare Protective Barrier Wipes;
New Exception Status: Avodart 0.5mg Cap;
Not Insured: Ciprodex Otic Suspension, Forteo 250mcg/mL Inj, Gynazole 1 Vag Cr; PIN changes to AeroChamber products;
New Interfchangeable Products: Gliclazide 80mg Tab, Paroxetine 20mg, 30mg Tabs
Posted March 4, 2005
Alberta
Additions effective March 1, 2005
Highlights
New Restricted Benefit (65 years and over): Avodart 0.5mg Cap;
New Special Authorization: Avodart 0.5mg Cap;
New Interchangeable Product: Novo-Levofloxacin 250mg, 500mg Tab;
New Product: Teveten Plus 600mg*12.5mg Tab
Posted March 2, 2005
Ontario
Revised Update F effective February 22, 2005
Highlights
Full Benefits: Betaderm 0.5% Cr, Oint, 0.1% Oint, Nyaderm 100000U/g Cr, Taro-Sone 0.05% Cr, Triaderm 0.1% Cr;
Limited Use Change: Arimide4x 1mg Tab, new criteria code 396.
Posted March 1, 2005
New Brunswick
MAP List Update March 1, 2005
Posted February 24, 2005
Alberta
DBL Report
Highlights
Status Change: Full benefit to Special Authoriztion effective March 1, 2005: Ampicillin (all brands), Cefadroxil (all brands), Primaxin 205mg/250mg & 500mg/500mg Inj, Tazocin 2G/250mg, 3G/375mg & 4G/500mg Inj, Vancocin 125mg & 250mg Cap;
Revisions to SA Criteria: Linezold 600mg Tab, Merrem 500mg & 1G Inj;
New SA effective January 1, 2005: Ketek 400mg Tab;
Listed products: Methotrexate 10mg Tab, Apo-Ateniidone 50/25mg, 100/25mg, Gen-Mirtazapine 30mg Tab;
Special Authorization Added: Cmbigan 02%/0.5% Opht Sol,
Special Authorization Criteria Change: Valcyte 450mg Tab;
Discontinued Listings effective January 1, 2005: Cefaclor, Bacitracin, Cefizox, Cefotan, Cefoxitin Sodium, Hip-Rex, Mandelamine, Monurol, Neggram, Pediazole, Pondocillin, Timentin, Zinacef;
Delisted Benefits effective April 1, 2005: Selexid 200mg Tab, Penglobe 400mg Tab, Rovamycine-500 1,500,000 U Cap, etromycin 50mg/mL Inj
Posted February 16, 2005
Ontario
Update F1 effective February 24, 2005
Highlights
Product Addition: Novo-Bupropion SR 150mg Tab
Posted February 11, 2005
Ontario
Update F effective February 22, 2005
Highlights
Product Additions: Androderm 12.2mg Trans Patch, AndroGel 1% 2.5g, 5.0g Foil Packet, Cellcept 200mg/mL Rd for Orl Susp-175mL Pk, Cipro XL 500mg, 1000mg ER Tabs, Lescol XL 80mg ER Tab, Lovenox HP 120mg/0.8mL, 150mg/08mL Pref Syr-0.8mL Pks, MetroLotion 0.75% Top Lot-60mL Pk, Rapamune 1mg/mL O/L, Rapamune 1mg Tab, Remeron RD 15mg, 30mg, 45mg Orl Dis Tab, Vagifem 25mcg Vag Tab, Zyprexa Zydis 15mg Rap Dis Tab;
Not a Benefit: Atropine, Indocid, Panoxyl Aquagel, Vivelle, Voltaren;
Limited Use Change: Arimidex 1mg Tab;
Diabetec Testing Agent Change: BD Test Strip,
Changes to Nutrition Products: Jevity; multiple discontinued products and drug price changes: see bulletin.
Posted February 10, 2005
Québec
Formulary Update February 2005
Highlights
Regular Listing Additions: Remeron RD 15mg, 30mg, 45mg Tab O/DIS, Tiazac XC 120mg,180mg, 240mg, 300mg, 360mg Tab ER;
New Exception Status Listings: Oxytrol 36mg Trans Pad, Pegasys RBV 200mg-180mg/0.5mL, 200mg-180mg/1mL Inj Sol Tab Kit, Prometrium 100mg Cap, Remodulin 1mg/mL, 2.5mg/mL, 5mg/mL, 10mg/mL Inj Sol, Alimta 550mg Inj Pd;
Changes to Status Exception to Regular: Alphagan P 0.15% Oph Sol, Dalacin T 1% Top Sol,
Changes to Exception Status: Elidel 1% Top Crm, Eprex (all strengths) Inj Sol, Fludara 10mg Tab, Neupogen 3200mcg/mL 1mL, 1.6mL Inj Sol, Protopic 0.03%, 0.1% Top Oint, Pegetron 200mg-50mcg/0.5mL, 200mg-80mcg/0.5mL, 200mg-100mcg/0.5mL, 200mg-120mcg/0.5mL, 200mg-150mcg/0.5mL;
New Criteria for Exception Status: Fludara 50mg IV Pws, Delisted: Ratio-Nystatin 100,000u/g Vag Crm;
Declined: Aldurazyme, Cerezyme, Forteo, Iressa, Levaquin, Penlac,Senspar, Aldara, Gynazole; See bullletin for details.
Posted February 9, 2005
New Brunswick
MAP List Update February 9, 2005
Posted February 8, 2005
Alberta
Quarterly Report Alberta Human Resources January 1, 2005
Highlights
New Special Authorization: Boost Oral Poudding, Combigan 0.2%*0.5% Opht Sol, Duocal Nutritional Powder, Ketek 400mg Tab, Kotocal Nutritional Powder, Pegasys RBV 180mcg inj vial*200 and syringe*200mg Tab Kit;
Changed to Special Authorization Status: Apo-Ampi 250mg, 500mg Caps, Apo-Ampi 25mg/mL, 50mg/mL Susp, Apo-Cefadroxil 500mg Cap, Duricef 50mg Cap, Novo-Ampicillin 250mg, 500mg Caps, Novo-Cefadroxil 500mg Cp, Nu-Ampi 250mg, 500mg Caps, Nu-Amp 25mg/mL, 50mg/mL Susp, Primaxin 250mg*250mg/vial, 500mg*500mg/vial injs, Tazocin 2g*250mg/vial 3g*375mg/vial, 4g*500mg/vial Injs, Vancocin 125mg, 250mg Caps;
Changes to Criteria: Merrem 500mg/vil inj, 1g/vial inj, Valcyte 450mg Tab, Zyvoxam 600mg Tab
Posted February 8, 2005
Alberta
Quarterly Report Alberta Health & Wellness January 1, 2005
Highlights
Added Products: Apo-Amiloride 5mg Tab, Apo-Atenidone 50mg*25mg, 100mg*25mg Tabs, Apo-Quinine 200mg, 300mg Caps, Co Atenolol 50mg, 100mg Tabs, Co Fluvoxamine 50mg, 100mg Tabs, Co Lovastatin 20mg, 40mg Tabs, Gen-Mirtazapine 30mg Tab, Methotrexate 10mg Tab, Novo-Citalopram 20mg, 40mg Tabs, Novo-Zopiclone 5mg, 7.5mg Tabs, Pms-Simvastatin 5mg, 10mg, 20mg, 40mg 80mg Tabs, Ratio-Amcinonide 0.1% TopLot and Top Oint, Rhoxal-Gliclazide 80mg Tab;
Deleted Products: Apo-Cefaclor 250mg, 500mg Caps, Apo-Cefaclor 25mg/mL 50mg/mL, 75mg/mL Orl Susp, Bacitracin 50,000 u/vial Inj, Ceclor 250mg, 500mg, Caps, Ceclor 25mg/mL, 50mg/mL, 75mg/mL Orl Susp, Cefizox 1g/Vial, 2g/Vial Inj, Cefotan 1g/vial, 1g/vial Inj, Cefoxitin Sodium 1g/vial, 2g/vial Inj, HIP-REX 1g tab, Madelamine 500mg Tab, Monurol 3g Sachet Orl Pwd Pkt, Neggram 500mg Cap, Netromycin 50mg/mL Inj, Novo-Cefaclor 250mg, 500mg Caps, No-Cefaclor 250mg, 500mg Caps, Pediazole 50mg/mL*120 mg/mL Orl Susp, Penglobe 400mg Tab, Pms-Cefaclor 250mg, 500mg Caps, Pms-Cefaclor 25mg/mL 50mg/mL, 75mg/mL Orl Susp, Pondocillin 35mg/mL Orl Susp, Pondocillin 500mg Tab, Rovamycine-500 1,500,000 Unit Cap, Selexid 200mg Tab, Timentin 3g*100mg/Vial Inj, Zinacef 750 mg/Vial, 1.5g/Vial Inj, Vioxx 12.5mg, 25mg Tabs; Special Authorization New Products: Combigan 0.2%*0.5% Opht Sol, Ketek 400mg Tab, Pegasys RBV 180mcg Inj Vial and Syringe*200mg Tab Kits,
Changed to Special Authorization Status: Apo-Ampi 250mg, 500mg Caps, Apo-Ampi 25mg/mL, 50mg/mL Susp, Apo-Cefdroxil 50mg Cap, Duricef 500mg Cap, Novo-Ampicillin 250mg, 500mg Caps, Novo-Cefadroxil 500mg Cap, Nu-Ampi 250mg, 500mg Caps, Nu-Ampi 25mg/mL, 50mg/mL Susp, Primaxin 250mg*250mg/Vial, 500mg*500mg/Vial Injs, Tazocin 2g*250mg/Vial 36*375mg/vial 4g*500mg/Vial Injs, Vancocin 125mg, 250mg Caps;
Changes to SA Criteria: Merrem 500mg/Vial, 1g/vial Inj, Valcyte 450mg Tab, Zyvoxam 600mg Tab;
Discontinued Products: Aralen, Benazac, Cytovene, Fulvicin U/F, Macrodantin, Norpace-CR, Ratio-jhaloperidol, Roferon-A, Salofalk, Sans-Acne Topical Lotion, Serc, Stieva-A, Ultradol
Posted February 8, 2005
Nova Scotia
February 2005 Bulletin
Highlights
Ostomy Supplies have new PINs and the old ones will be discontinued April 1, 2005.
New Maximum Allowable Costs effective February 15, 2005 for Gentamicin 0.3% Otic Sol, Leflunomide 10mg, 20mg Tabs, Methotrexate 2.4mg Tab
Posted February 2, 2005
Nova Scotia
January 2005 Bulletin
Highlights
Updates to the Maximum Allowable Cost List effective February 1, 2005;
Exception Criteria Addition: Etanercept; New Exception Status Drug: Serc 8mg, 16mg, Pegetron Redipen 80mcg/0.5mL Inj/200mg, 100mcg/0.5mL Inj/200mg, 120mcg/0.5mL Inj/200mg, 150mcg/0.5mL Inj/200mg Cap; effective February 1, 2005;
New Full Benefits: pms-Diazepan 2mg, 5mg, 10mg Tab;
Not Listed Benefits: Adderall XR 5mg, 10mg, 15mg, 20mg, 25mg, 30mg Caps, Concerta 18mg, 36mg, 54mg Tabs, Meridia 10mg, 15mg Caps, Neulasta 10mg/mL Inj, Remodulin 1mg/mL, 2.5mg/mL, 5mg/mL, 10mg/mL Inj, Xenical 120mg Cap, Zavesca 100mg Cap;
Delisted Products: Adriamycin PFS 2mg/mL Inj, Amikacin 250mg/mL Inj, Amikin 250mg/mL Inj, BiCNU 100mg Inj, Blenoxane 15u/mL Inj, CefoxitinSodium 1g, 2g/Vial Inj, Cerubidine 20mg/vial Inj, Cosmegen 500mcg/vial Inj, Cytosar 100mg, 500mg/vial Inj, Digoxin 0.05mg, 0.25mg /mL Inj, Fraxiparine 9500 anti-Xa iu/mL Inj, Fraxiparine Forte 19000 anti-Xa iu/mL, Indocid PDA 1mg/mL Inj, Isoproterenol HCI 0.2mg/mL Inj, Kidrolase 10,000 iu/vial Inj, Labetalol HCI 5mg/mL Inj, Levophed 1mg/mL Inj, Lopresor 1mg/mL Inj, Mutamycin 5mg/vial Inj, Naloxone 0.4mg/mL 1mg/mL Inj, Neo-Bex Inj, Nipride 50mg/5mL Inj, Norepinephrine Bitartrate 1mg/mL Inj, Norflex 30mg/mL Inj, Novantrone 2mg/mL Inj, Procainamide 100mg/mL Inj, Prostin VR 500mcg/mL Inj, Suprefact 1mg/mL Inj, Synacthen 1mg/mL Depot Inj, Ventolin 0.5mg/mL IM Inj, 1mg/mL Infusion Sol, Vepasid 100mg/vial Inj, Xylocard 100mg/5mL Inj, Zanosar 1g/vial Pdr Cake;
Manufacturer Discontinued Products: See bulletin
Posted February 2, 2005
Nova Scotia
Formulary February 2005
Posted February 1, 2005
New Brunswick
February 2005 MAP List
Posted January 27, 2005
New Brunswick
Bulletin, January 26, 2005
Highlights
New Regular Benefits: Biaxin 125mg/5mL, 150mg/5mL PWS; DDAVP 0.1mg, 0.2mg Tab;
New Special Authorizations: Fludara 10mg Tab, Keppra 250mg, 500mg, 750mg Tab, Zyprexa 2.5mg, 5mg, 7.5mg, 10mg, 15mg Tab, Zyprexa Zydis 5mg, 10mg Tab, Trileptal 150mg, 300mg, 600mg Tab, 60mg/mL Susp, Thyrogen 0.9mg/mL Inj, Pegasys 180mcg/0.5mL PF Syg, 180mcg/mL Vial;
Drugs Not Listed: Pennsaid, Concerta
Posted January 25, 2005
Ontario
Update, January 25, 2005
Highlights
New Full Benefits: Gen-Fosinopril 10mg, 20mg Tabs, PMS-Methimazole 5mg Tab, Rhoxal-acebutolol 100mg, 200mg, 400mg Tabs, Rhoxal-sotalol 160mg ; New Limited Use Benefits: Co-Etidronate 200mg Tab, Novo-Leflunomide 10mg, 20mg Tabs, Novo-Levofloxacin 250mg, 500mg Tabs
Posted January 19, 2005
Newfoundland/Labrador
Benefit List and Interchangeable List - January 2005
Posted January 11, 2005
New Brunswick
January 2005 MAP List
Posted January 4, 2005
Saskatchewan
Bulletin 101, January 1 2005
Highlights
New Full Listings: Tiazac XC 120mg, 180mg, 240mg, 300mg, 360mg ER Tabs, Remeron RD 15mg, 30mg, 45mg Tabs;
New Full Listing Interchangeables: Sab-Trifluridine 1% Opht Sol, Dom-Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg Tabs, CO-Lovastatin 20mg, 40mg Tabs, Gen-Diltiazem 120mg, 180mg, 240mg, 300mg Cap, Gen-Mirtazapine 15mg, 30mg, 45mg Tabs;
New Interchangeable Exepction Drug Status: Apo-Clonidine 0.025mg Tab, Apo-Bisoprolol 5mg, 10mg Tabs, Gen-Meloxicam 7.5mg,15mg Tabs;
New Exception Drug Status: Nutropin AQ Pen 10mg Inj Cart, Pegetron Redipen, Pegasys RBV, Pegasys;
Exception Status Revised Criteria: Valcyte 450mg Tab, Inron-A, Referon A, Unitron Peg, Rebetron, Pegetron, Cipro XL;
Under Review: Apo-Clozapine, Gen-Clozapine, Apo-Cyclosporine, Rhoxal-Cyclosporine, Zavesca, Cipro XL, Adderall XR;
Not Recommended: Zyprexa IM, Synthroid, Viread, Tamiflu;
Note: Flolan Injection does not go through the pharmacy online process but it is provided at no charge to patients who have prior approval and the pharmacy bills manually.
|
